Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Analyze when to tilt toward stocks or bonds in retirement. A practical guide to selecting the right index mix for your goals.
22,201 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
A new nationwide survey finds 39% of Americans store unused electronics in drawers, while only 10% are recycled or re...
June markets test XLE as oil dynamics and earnings timing hedges collide. A handful of energy giants drive the ETF, u...
As SpaceX captures headlines, a quieter but powerful growth wave is building in quantum computing. This guide highlig...
Luxembourg regulators grant Ripple a preliminary CASP license under MiCA, unlocking cross‑EU rollout for RLUSD. XRP t...
Oil prices retreat in mid-2026, but mortgage rates haven’t followed, leaving borrowers facing higher payments. Here's...
Analysts see strong demand for Nvidia's AI hardware and software ecosystem. This piece breaks down why great news NVI...
Inflation has squeezed most Americans, but American Express remains focused on the affluent. This article examines wh...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...
Apple quietly hiking prices on Mac and iPad models signals a shift in pricing strategy as memory costs rise, with inv...
JPMorgan Chase just paired a 10% dividend hike with a $50 billion buyback after clearing the Fed's stress test. Here'...
Tower Semiconductor faced a notable drop as AI-driven demand and profitability questions swirl. This guide breaks dow...